Allergen Immunotherapy : Tunisian Society of Respiratory Diseases and Allergology Guidelines

##plugins.themes.academic_pro.article.sidebar##

Published Mar 16, 2018
Download
pdf
Vol. 95 No. 8 (2017): Issue Aug 2017

##plugins.themes.academic_pro.article.main##

Fatma Tritar
Majed Béji
A Ben Khedher
Mohamed Ridha Charfi
A. El Kamel
K. Rekik
H. Daghfous
J. Ammar
S. Azabi
Z. Souissi
S. Taktak
Ikram Drira
M. Smaoui
Boubaker Zakhama

##plugins.themes.academic_pro.article.details##

References

  1. Burks AW, Calderon MA, Casale T et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. The Journal of allergy and clinical immunology 2013, 131(5): 1288-1296.
  2. Calderón MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P.Allergen specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy ClinImmunol 2011, 127: 30-8.
  3. Calderón MA, Simons FE, Malling HJ, Lockey RF, Moingeon P, Demoly P.Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy 2012; 67(3):302-11.
  4. Canonica GW, Bousquet J, Casale T. Sub-lingual immunotherapy: World Allergy Organization position paper 2009. Allergy 2009; 64(suppl 91):1-59.
  5. Matricardi PM, Kuna P, Panetta V, Wahn U, Narkus A. Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses. J Allergy ClinImmunol 2011; 128(4):791-799.
  6. Cox L, Calderón M, Pfaar O. Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations. Immunotherapy 2012; 4(6): 601-16.
  7. Asamoah F, Kakourou A, Dhami S et al. Allergenimmunotherapy for allergicasthma: a systematicoverview of systematicreviews. Clin TranslAllergy. 2017 Aug 2;7:25. doi: 10.1186/s13601-017-0160-0. eCollection 2017
  8. Compalati E, Rogkakou A, Passalacqua G, Canonica GW. Evidences of efficacy of allergen immunotherapy in atopic dermatitis: an updated review. CurrOpin Allergy ClinImmunol 2012; 12: 427-33.
  9. Nurmatov U, Dhami S, Arasi S, et al. Allergen immunotherapy for allergicrhinoconjunctivitis: a systematicoverview of systematic reviews. Clin Transl Allergy. 2017 Aug 8;7:24. doi: 10.1186/s13601-017-0159-6. eCollection 2017
  10. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmaticchildrenmonosensitized to house dust mite by specificimmunotherapy. A six-yearfollow-up study. Clin ExpAllergy. 2001 Sep;31(9):1392-7.
  11. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-yearfollow-up after discontinuation of preseasonalgrass pollen immunotherapy in childhood. Allergy. 2006 Feb;61(2):198-201.
  12. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Long-lasting effects of sublingual immunotherapyaccording to its duration: a 15-year prospective study. J Allergy Clin Immunol. 2010 Nov;126(5):969-75
  13. Asero R. Injection immunotherapy with different airborne allergens did not prevent de novo sensitization to ragweed and birch pollen north of Milan. Int Arch Allergy Immunol 2004; 133(1): 49-54.
  14. GulenF Zeyrek D, Can Det al. Development of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. Asian Pac J Allergy Immunol 2007; 25(1): 7-11.
  15. Harmanci K Razi CH, Toyran M, Kanmaz G, Cengizlier MR.Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. Asian Pac J Allergy Immunol 2010; 28. (1): 7-13.
  16. Halken S, Larenas-Linnemann D, Roberts G et al.EAACI Guidelines on Allergen Immunotherapy: Prevention of allergy.Pediatr Allergy Immunol. 2017 Sep 13.doi: 10.1111/pai.12807
  17. Bernstein DI, Bardelas JA Jr, SvanholmFogh B, Kaur A, Li Z, Nolte H. A practicalguide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.Postgrad Med. 2017 Aug;129(6):590-597.
  18. Yin GQ, Jiang WH, Wu PQ, He CH, Chen RS, Deng L. Clinicalevaluation of sublingual administration of dust mite drops in the treatment of allergic asthma and allergicrhinitis of children.EurRev Med PharmacolSci. 2016 Oct;20(20):4348-4353.
  19. Nolte H, Bernstein DI, Nelson HS et al. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2016 Dec;138(6):1631-1638.
  20. Calderón MA, Bousquet J, Canonica GW et al.Guideline recommendations on the use of allergen immunotherapy in house dust mite allergy: Time for a change? J Allergy Clin Immunol. 2017 Jul;140(1):41-52.
  21. Durham, S.R Walker SM, Varga EMet al. Long-term clinical efficacy of grass-pollen immunotherapy. The New England journal of medicine 1999. 341(7): 468-75.
  22. Jacobsen L Niggemann B, Dreborg Set al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62(8):943-8.
  23. Hankin CS Cox L, Bronstone A, Wang Z. Allergy immunotherapy: reduced healthcare costs in adults and children with allergic rhinitis. J Allergy Clin Immunol 2013 131(4):1084-91
  24. Jutel M Agache I, Bonini Set al. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy ClinImmunol 2016; 137(2):358-68.
  25. Hankin CS, Cox L, Bronstone A, Wang Z. Allergyimmunotherapy: reducedhealth care costs in adults and childrenwithallergicrhinitis. J Allergy Clin Immunol. 2013 Apr;131(4):1084-91